×

FDA Warns Six Companies for Selling Misbranded Topical Pain-Relief Products with Excessive Lidocaine Content

FDA cautions that widely used pain-relief creams could present serious health hazards

FDA Warns Six Companies for Selling Misbranded Topical Pain-Relief Products with Excessive Lidocaine Content

Recently, the U.S. Food and Drug Administration (FDA) issued a warning to six companies for selling unapproved and misbranded over-the-counter topical pain-relief products containing higher-than-allowed concentrations of lidocaine, a local anesthetic. Jill Furman, director of the Office of Compliance in the FDA’s Center for Drug Evaluation and Research, emphasized the risks associated with these products and advised that they should not be on the market due to their potential harm to consumers.

The problem with these products lies in their excessive lidocaine content, which can lead to serious side effects such as irregular heartbeat, seizures, and breathing difficulties when used on large areas of skin or irritated skin. To prevent adverse effects, the FDA recommends avoiding products containing more than 4% lidocaine, refraining from usage on large areas of skin, and avoiding wrapping the product with dressings or plastic wraps.

Some of the products cited by the FDA in their warning include TKTX Numb Maximum Strength Pain Reliever, NumbSkin Lidocaine Numbing Creams, and Signature Tattoo Numbing Cream. It is crucial to heed these warnings to protect your health and well-being while undergoing cosmetic procedures that involve microdermabrasion treatments, laser hair removal tattoos or piercings. For more detailed information on specific products mentioned in the FDA’s warning, interested individuals can refer to the official press release from the U.S. Food and Drug Administration.

It is essential for individuals who regularly undergo cosmetic procedures involving pain relief to take note of this warning from the U.S Food and Drug Administration (FDA) regarding certain over-the-counter topical pain relief products containing lidocaine as a local anesthetic.

Jill Furman emphasized that these products pose a risk to consumers due to their excessive lidocaine content’s potential harmful side effects such as irregular heartbeat, seizures, and breathing difficulties when used on large areas of skin or irritated skin.

To avoid adverse effects caused by these products’ use during cosmetic procedures involving microdermabrasion treatments laser hair removal tattoos or piercings it is recommended by the FDA that individuals avoid using any product containing more than 4% lidocaine content while refraining from usage on large areas of skin.

The FDA has cited some examples of misbranded over-the-counter topical pain relief products including TKTX Numb Maximum Strength Pain Reliever; NumbSkin Lidocaine Numbing Creams; Signature Tattoo Numbing Cream among others.

It is vital for individuals who regularly undergo cosmetic procedures involving pain relief to consult with their medical practitioners before using any product containing lidocaine as a local anesthetic while taking note of this warning from US Food & Drug Administration (FDA).

You May Have Missed